Lactobacillus acidophilus HA-122
Lactobacillus acidophilus HA-122 (tyndallized form) has limited strain-specific published evidence in the indexed research base. The primary study identified is an open randomized controlled trial evaluating a combination product (a standardized herbal extract plus tyndallized L. acidophilus HA-122) for infantile colic, though the multi-ingredient design makes it difficult to attribute any outcome to this strain alone. L. acidophilus as a species has a broader literature examining gut health and immune function, though strain-level extrapolation should be made cautiously. Additional strain-specific clinical research would be needed to characterize HA-122's independent effects. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
1 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.